AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies

Contributed by: Business Wire

Logo

Tags

Health

Infectious Diseases

Clinical Trials

Research

Science

Pharmaceutical

Biotechnology

WODC

More Like This

Global End-to-End Solutions Partner to Life Sciences Organisations, AscellaHealth, Joins Manchester Science Park

(Photo: Business Wire)

AscellaHealth Expands Global Leadership Team: Specialty Pharmaceutical Experts with Manufacturer and Payer Expertise Propel International Growth

AscellaHealth Identifies Key Health Trends for 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry

AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem

AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services

PR Newswire associated0

Biopharma Leaders Shape the Future of Drug Development at Veeva R&D and Quality Summit Europe

Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress

Calliditas Therapeutics to Attend Conferences in April